| UPDATED: 13:54, Tue, Feb 2, 2021
Link copied Sign up for our columnists plus the most commented stories driving conversation
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
The EU was the subject of widespread criticism last week following its row with Swedish pharmaceutical company AstraZeneca. Brussels was furious when the company said it woud be unable to fulfil its delivery on vaccines to the bloc. In fact, it was suggested as little as a quarter of the agreed amount of jabs – but AstraZeneca maintained the UK s vaccines would not be affected. Brussels chief von der Leyen then argued it was “crystal clear” that the contract required AstraZeneca to deliver doses produced in the UK to the EU to m